Current pharmacotherapies for atherosclerotic cardiovascular diseases
Sign Up to like & getrecommendations! Published in 2019 at "Archives of Pharmacal Research"
DOI: 10.1007/s12272-019-01116-1
Abstract: Despite the introduction of statins for lowering LDL-C level, atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of death and morbidity worldwide. Combination therapies with statin and other lipid-lowering drugs, including ezetimibe and proprotein convertase… read more here.
Keywords: current pharmacotherapies; atherosclerotic cardiovascular; treatment; cardiovascular diseases ... See more keywords
Current pharmacotherapies for sarcopenia
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2019.1622093
Abstract: ABSTRACT Introduction: Sarcopenia, the age-related loss of skeletal muscle mass and function, is a global health problem that contributes to the development of physical disability, morbidity and mortality in the ageing population. Sarcopenia is now… read more here.
Keywords: sarcopenia; pharmacotherapies sarcopenia; current pharmacotherapies;